dc.relation.reference | 王思涓。2002。薏苡籽實中特殊生理機能性成分的定量分析與比較。國立臺灣大學食品科技研究所碩士論文。台北。
行政院衛生署。1998。台灣地區食品營養成分資料庫。行政院衛生署。台北。
江文章、徐明麗、蘇瑞斌、龐飛。2000。薏仁加工食品輔助抑制腫瘤功效之評估。醫護科技學刊 2(2):113-122。
江文章。1997。上品養命藥-薏仁的營養價值和特殊機能。鄉間小路23(12):48-51。
吳宜娟。2001。薏仁加工產品對高血脂質大鼠代謝之影響。國立臺灣大學食品科技研究所碩士論文。台北。
李大鵬。1996。康萊特注射液治療原發性肺癌臨床報告。中醫雜誌 37:411-414。
李鳳云,陳浩然,馮曉東,柳世英,姜力。1994。中藥薏苡仁抗腫瘤作用的研究。實用腫瘤學雜誌3 : 59。
杜姿瑩。1999。糙薏仁降血脂作用之研究。國立臺灣大學食品科技研究所碩士論文。台北。
林方宜。1999。薏苡種皮油溶性成分之分離與純化。國立臺灣大學食品科技研究所碩士論文。台北。
施宛宜。2001。以細胞模式探討薏苡籽實萃取物對COX-2和iNOS表現的影響。國立臺灣大學食品科技研究所碩士論文。台北。
施宛宜。2002。薏苡分離純化之純物質對抗腫瘤血管新生的效應(未發表)。
夏詩閔。2001。薏苡籽實萃取物對於大鼠卵巢性類固醇激素以及腦下腺黃體促進素和濾泡刺激素分泌之效應。國立臺灣大學食品科技研究所碩士論文。台北。
徐明麗。1997。薏仁抗過敏與抗腫瘤之研究。國立臺灣大學食品科技研究所碩士論文。台北。
徐欣億。2003。糙薏仁對特異性免疫反應及呼吸道發炎影響之研究。國立臺灣大學食品科技研究所博士論文。台北。
涂予彣。2002。薏仁、山渣、荷葉與陳皮水萃取物對倉鼠脂質代謝的影響。國立臺灣大學食品科技研究所碩士論文。台北。
張政信。2002。不同糙薏仁材料對BAL/c鼠非特異性免疫反應之影響。國立臺灣大學食品科技研究所碩士論文。台北。
國家衛生研究院。1998。大腸直腸癌診斷與治療之共識。國家衛生研究院。台北。
郭靜娟。2001。薏苡籽實之抗氧化成分及其抑制自由基傷害之研究。國立臺灣大學食品科技研究所博士論文。台北。
程金燕。1998。糙薏仁對大鼠腸道生理機能性的影響。國立臺灣大學食品科技研究所碩士論文。台北。
黃士禮與江文章。1999。薏苡籽實各部位之組成及其丙酮萃取液之抗突變作用。食品科學26:121-130。
黃士禮。1996。薏苡籽實貯藏條件、抗突變效應及抗腫瘤效應之研究。國立臺灣大學食品科技研究所博士論文。台北。
黃詠凱。2002。不同產地的糙薏仁對倉鼠脂質代謝之影響。國立臺灣大學食品科技研究所碩士論文。台北。
黃博偉。2003。不同糙薏仁成分對糖尿病大白鼠醣代謝級脂質代謝的影響。國立臺灣大學食品科技研究所博士論文。台北。
葉芝嵐。2002。薏苡殼醇類萃取物對大鼠卵巢性類固醇激素分泌之效應。國立臺灣大學食品科技研究所碩士論文。台北。
劉桂萍。2000。薏苡殼甲醇萃取物清除自由基成分之分離與純化。國立臺灣大學食品科技研究所碩士論文。台北。
蔡至宏。1997。薏苡種皮水溶性物質之抗致突變性及其分離與純化。國立臺灣大學食品科技研究所碩士論文。台北。
簡雅琳。1998。薏苡殼油溶性萃取物的抗突變性成分之分離與純化。國立臺灣大學食品科技研究所碩士論文。台北。
中山宗春。1960。薏苡仁抗癌作用之研究。日本外科學會誌,61:234。(日文)
中山恆明。1959。漢方藥療法之經驗。日本醫師會雜誌,41(12).945-950。(日文)
六城雅彙、西原哲三、浮田忠之進、井口定男。1950。各種藥物對吉田肉瘤之增殖阻止作用。Gann (Jpn. J. Cancer Res.) 41:91-92.(日文)
Ahnen, D.J. 1999. Tissue markers of colon cancer risk. Gastroint. Endosc. 49:S50-S59.
Alabaster, O., Tang, Z.C., Frost, A., and Shivapurkar, N. 1995. Effect of β-carotene and bran fiber colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis 16:127-132.
American Institute of Nutrition 1977. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J. Nutr. 107:1340-1348.
American Institute of Nutrition 1980. Second report of the ad hoc committee on standards for nutritional studies. J. Nutr. 110:1726.
Ary, M.B, Shewry, P.R., and Richardson, M. 1988. The aminoacid sequence of a cereal Bowman-birk type trypsin inhibitor from seeds of Job’s ters (Coix lachryma-jobi L.). FEBS Lett. 229:111-118.
Association of Official Analytical Chemists 1980. Official Methods of Analysis, 13th ed. AOAC, Washington DC.
Awad, A.B. and Fink, C.S. 2000. Phytosterols as anticancer dietary components: evidence and mechanism of action. J. Nutr. 130:2127-2130.
Bamba, H., Ota, S., Kato, A., Adachi, A., Itoyama, S., and Matsuzaki, F. 1999. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int. J. Cancer 83:470-475.
Bartsch, H., Nair, J., and Owen, R.W. 1999. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role risk modifiers. Cacinogenesis 20:2209-2218.
Beaty, M.M., Lee, E.Y., and Glauert, H.P. 1993. Influence of dietary calcium and vitamin D on colon epithelial cell proliferation and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats fed high fat diets. J. Nutr. 123:144-152.
Bertagnolli, M.M. 2002. Chemoprevention of colorectal cancer. In Colorectal Cancer, L.B. Saltz (Ed), p81-98, Human Press Inc., Totowa, NJ.
Billings, P.C., Newberne, P.M., and Kennedy, A.R. 1990. Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine. Carcinogenesis 11:1083-1086.
Bird, R.P. 1987. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37:147-151.
Bird, R.P. 1995. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93:55-71.
Bird, R.P. 1998. Aberrant crypt foci system to study cancer preventive agents in the colon. In Methods in Molecular Medicine, Vol.14, M. Hanausek and Z. Walaszek (Ed), p465-474, Humana Press Inc., Totowa, NJ.
Bird, R.P. and Good, C.K. 2000. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol. Lett. 112-113:395-402.
Burnstein, M.J. 1993. Dietary factors related to colorectal neoplasms. Surg. Clin. North Am. 73:13-29.
Caderni, G., Giannini, A., Lancioni, L., Luceri, C., Biggeri, A., and Dolara, P. 1995. Characterization of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. Brit. J. Cancer 71:763-769.
Cameron, I.L., Hardman, W.E., and Heitman, D.W. 1997. The nonfermentable dietary fiber lignin alters putative colon cancer risk factors but does not protect against DMH-induced colon cancer in rats. Nutr. Cancer 28:170-176.
Cameron, I.L., Hardman, W.E., and Heitman, D.W. 1997. The nonfermentable dietary fiber lignin alters putative colon cancer risk factors but does not protect against DMH-induced colon cancer in rats. Cancer Res. 28:170-176.
Cassand, P., Maziere, S., Champ, M., Meflah, K., Bornet, F., and Narbonne, J.F. 1997. Effect of resistant starch- and vitamin A-supplemented diets on the promotion of precursor lesions of colon cancer in rats. Nutr. Cancer 27:53-59.
Chan, T.A. 2002. Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer. Lancet Oncol. 3:166-174.
Chang, H.-C., Huang, Y.-C., and Hung, W.-C. 2003. Antiproliferative and chemopreventive effects of adlay seed on lung cancer in vitro and in vivo. J. Agric. Food Chem. 51:3656-3660.
Chen, W.-S., Wei, S.-J., Liu, J.M., Hsiao, M., Kuo-Lin, J., and Yang, W.K. 2001. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. Int. J. Cancer. 91:894-899.
Compher, C.W., Frankel, W.L., Tazelaar, J., Lawson, J.A., Mckinney, S., Segall, S., Kinosian, B.P., Williams, N.N., and Rombeau, J.L. 1999. Wheat bran decreases aberrant crypt foci, preserves normal proliferation, and increases intraluminal butyrate levels in experimental colon cancer. J. Parenteral Enteral Nutr.23:269-278.
Compton, C.C. 2001. Pathology and staging. In Cancer of the Lower Gastrointestinal Tract, C.G. Willett (Ed), p53-81, B.C. Decker Inc., Hamilton.
Corpet, D.E., Parnaud, G., Delverdier, M., Peiffer, G., and Tache, S. 2000. Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens. Cancer Res. 60:3160-3164.
Corpet, D.E. and Tache, S. 2002. Most effective colon cancer chemopreventive agents in rats: A systemic review of aberrant crypt foci and tumor data, ranked by potency. Nutr. Cancer 43:1-21.
Dannenberg, A.J. and Zakim, D. 1999. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Semin. Oncol. 26:499-504.
Davies, M.J., Bowey, E.A., Adlercreutz, H., Rowland, I.R., and Rumsby, P.C. 1999. Effect of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats. Carcinogenesis 20:927-931.
Davis, P.A. and Iwahashi, C.K. 2001. Whole almond fractions reduce aberrant crypt foci in a rat model of colon carcinogenesis. Cancer Lett. 165:27-33.
De Flora, S., Bennicelli, C., and Bagnasco, M. 1999. Rationale and mechanism of cancer chemoprevention. In Chemoprevention of Cancer: A Clinical Update, H.-J. Seen, A, Costa, and V.C. Jordan (Ed), p.29-44, Spring-Verlag Berlin, Heidelberg, Berlin.
Dimberg, J., Samuelsson, A., Hugander, A., and Soderkvist, P. 1999. Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut 45:730-732.
Dolara, P., Caderni, G., and Luceri, C. 2000. Surrogate endpoint biomarkers for human colon carcinogenesis. Toxicol Lett. 112-113:415-420.
Drasar, B.S. and Irving, D. 1973. Environmental factors and cancer of the colon and breast. Br. J. cancer 27:167-172.
DuBois, R.N., Radhika, A., Reddy, B.S., and Entingh, A.J. 1996. Increased cyclooxygenase-s levels in carcinogen-induced rat colonic tumors. Gastroenterology 110:1259-1262.
Duke, J.A. 1992. Handbook of phytochemical constituents of GRAS herbs and other economic plants. CRC Press. Boca Raton. Florida.
Einspahr, J.G., Alberts, D.D., Gapstur, S.M., Bostick, R.M., Emerson, S.S., and Gerner, E.W. 1997. Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials. Cancer Epidemiol. Biomarkers & Prev. 6:37-48.
Elder, D.J.E., Baker, J.A., Banu, N.A., Moorghen, M., and Paraskeva, C. 2002. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-s expression. J. Pathol. 198:428-434.
Elsayed, A.M. and Shamsuddin, A.M. 1990. Neoplasms of the colon. In Atlas of Tumor Pathology of the Fischer Rat, S.F. Stinson, H.M. Schuller, and G.K. Reznik (Ed), p133-191, CRC Press, Inc., Boca Raton, Florida.
Exon, J.H., South, E.H., Magnuson, B.A., and Hendrix, K. 2001. Effects of indole-3-carbinol on immune responses, aberrant crypt foci, and colonic crypt cell proliferation in rats. J. Toxicol. Environ. Health Part A 62:561-573.
Femia, A.P., Dolara, P., and Caderni, G. 2004. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are usful biomarkers for colon carcinogenesis. Carcinogenesis 25:277-281.
Fiala, E.S. 1975. Investigations into the metabolism and mode of action of the colon carcinogen 1,2-dimethylhydrazine. Cancer 36:2407-2412.
Fiala, E.S., Joseph, C., Sohn, O.S., El-Bayoumy, K., and Reddy, B.S. 1991. Mechanisms of benzyl selenocyanate inhibition of azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 51:2826-2830.
Filipe, M.I. 1975. Mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine. A morphological and histochemical study. Br. J. Cancer 32:60-77.
Fournier, D.B. and Gordon, G.B. 2000. COX-2 and colon cancer: Potential targets for chemoprevention. J. Cell Biochem. Suppl. 34:97-102.
Fuchs, C.S. 2002. Dietary and lifestyle influences on colorectal carcinogenesus. In Colorectal Cancer, L.B. Saltz (Ed), p47-63, Human Press Inc., Totowa, NJ.
Fujita, M., Fukui, H., Kusaka, T., Ueda,Y., and Fujimori, T. 2000. Immunohistochemical expression of cyclooxygenase (COX)-2 in colorectal adenomas. J. Gastroenterol. 35:488-490.
Gannon, C.J., Malone, D.L., Royal, R.E., Schreiber, M., Bass, B.L., Napolitano, L.M. 2002. Advanced proximal colon cancer: Paucity of distal lesions validates screening colonscopy. Surg. Endosc. 16:446-449.
Garcia, M.D., Ahumada, M.C., and Saen, M.T. 1998. Cytostatic activity of some phenolic acids of Scrophularia frutescens L.var. frutescens. Zeitschrift fur Naturforschung C-A J. Biosciences 53:1093-1095.
Gupta, R.A. and DuBois, R.N. 2003. Cycooxygenase-2, prostaglandins, and colorectal carcinogenesis. In COX-2 Blockade in Cancer Prevention and Therapy, R.E. Harris (Ed), p159-169, Humana Press inc., Totowa, NJ.
Gustin, D.M. and Brenner, D.E. 2002. Chemoprevention of colon cancer: Current status and future prospects. Cancer Metastasis Rev. 21:323-348.
Hall, N.R. and Madoff, R.D. 2000. Genetic and the Polyp-Cancer sequence. In Colon and Rectal Cancer, P.S. Edelstein (Ed), p3-27, Wiley-Liss Inc., New York, NY.
Hamilton, S.R 1989. Experimental models of colorectal carcinogenesis. In Colorectal Cancer: From Pathogenesis to Prevention, H.K. Seitz, U.A. Simanowski, and N.A. Wright (Ed), p202-216, Spring-Verlag Berlin, Heidelberg, Berlin.
Hamilton, S.R. 1996. Pathology and biology of colorectal neoplasia.In Prevention and Early Detection of Colorectal Cancer, G.P. Young, P. Rozen, and B. Levin (Ed), p3-21, W.B. Saunders Company Ltd, London.
Han, J.-S., rhee, A.-H., and Cheigh, H.-S. 1988. Changes of lipid in raw and precessed adlay powder during storage. Korean J. Food Soc. Technol. 20:691-698.
Hermanek, P. 2002. Pathology of colorectal cancer. In Colorectal cancer a Clinical Guide to Therapy, H. Bleiber, N. Kemeny, P. Rougier, and H.Wilke (Ed), p55-72, Martin Dunitz Ltd, London.
Hirose, Y., Kuno, T., Tamada, Y., Sakata, K., Katayama, M., Yoshida, K., Qiao Z., Hata, K., Yoshimi, N., and Mori, H. 2003. Azoxymethane-induced beta-catenin-accumulated cypts in colonic mucosa of rodents as an intermediate biomarker fo colon carcinogenesis. Carcinogenesis 24:107-111.
Hla, T., Bishop-Bailey, D., Liu, C.H., Schaefers, H.J., and Trifan, O.C. 1999. Cyclooxygenase-1 and –2 isoenzymes. Int. J. Biochem. Cell Biol. 31:551-557.
Holt, P.R., Mokuolu, A.O., Distler, P., and Reddy, B.S. 1996. Region distribution of carcinogen-induced colonic neoplasia in the rat. Nutr. Cancer 125:129-135.
Hudson, E.A., Dinh, P.A., Kokubum, T., Simmonds, M.S.J., and Gescher, A. 2000. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiology, Biomarker and Prevention. 9:1163-1170.
Hughes, J.S., Ganthavorn, C., and Wilson-Sanders, S. 1997. Cy beans inhibit azoxymethane0induced colon carcinogenesis in F344 rats. J. Nutr. 127:2328-2333.
Hung W.-C. and Chang, H.-C. 2003. Methanolic extract of adlay seed suppress COX-2 expression of human lung cancer cells via inhibition of gene transcription. J. Agric. Food Chem. 51:7333-7337.
International Life Science Institute (ILSI) North America Technical Committee on Food Components for Health Promotion 1999. Safety assessment and potential health benefits of food components based on selected scientific criteria. Crit. Rev. Food Sci. Nutr. 39:203-316.
Ishizuka, S., Nagai, T., and Kasai, T. 1996, Administration of anti-asialo GM1 serum increases aberrant crypt foci induced by 1,2-dimethyhydrazine in the large bowel of rats. J. Nutr. Sci. Vitaminol. 42:603-608.
Jenab, M, Chen, J.-M., and Thompson, L.U. 2001. Siaolomucin production in aberrant crypt foci relates to degree of dysplasia and rate of cell proliferation. Cancer Lett. 165:19-25.
Jenab, M. and Thompson, L.U. 1998. The influence of phytic acid in wheat bran on early biomarkers of colon carcinogenesis. Carcinogenesis 19:1087-1092.
Kam, P.C.A. and See, A.U-L. 2000. Cyclo-oxygenase isoenzymes: Physiological and pharmacological role. Anaesthesia 55:442-449.
Kawada, M., Ohno, Y., Ri, Y., Ikoma, T., Yuugetu, H., Asai, T., Watanabe, M., Yasuda, N., Akao, S., Takemura, G., Minatoguchi, S., Gotoh, K., Fujiwara, H., and Fukuda, K. 2001. Anti-tumor effect of gallic acid on IL-2 lung cancer cells transplanted in mice. Anti-Cancer Drugs 12:847-852.
Kawamori, T., Rao, C.V., Seibert, K., and Reddy, B.S. 1998. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58:409-412.
Kawamori, T., Tanaka, T., Hara, A., Yamahara, J., and Mori, H. 1995. Modifying effects of naturally occurring product on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res. 55:1277-1282.
Kelloff, G.J., Boome, C.W., Sigman, C.C., and Greenwald, P. 1996. Chemoprevention of colorectal cancer. In Prevention and Early Detection of Colorectal Cancer. G.P. Young, P. Rozen, and B. Levin. (Ed), p115-139, W.B. Saunders Company Ltd, London.
Kelloff, G.J., Crowell, J.A., Steele, V.E., Lubet, R.A., Malone, W.A., Boone, C.W., Kopelovich, L., Hawk, E.T., Lieberman, R., Lawrence, J.A., Ali, I., Viner, J.L., and Sigman, C.C. 2000. Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents. J. Nutr. 130:467S-471S.
Kondo, Y., Nakajima, K., Nozoe, S., and Suzuki, S. 1988. Isolation of ovulatory active substances from crops of Job’s tears (Coix lachryma-jobi var. ma-yuen Stapf.). Chem. Pharm. Bull. 36:3147-3152.
Koratkar, R. and Rao, A.V. 1997. Effect of soya bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutr. Cancer 27:206-209.
Kubota, T., Haramaki, Y., Oki, Y., Saitoh, F., Kuorshima, A., and Numata, M. 1988. Antitumor activity of vinegar made from pearl barley grain. Nippon Nogeikagaku Kaishi 62:23-28.
Kune, G. 1996. Causes and Control of Colorectal Cancer. Kluwer Academic Publishers, Norwell, MA.
Kuo, C.-C., Shih, M.-C., Kuo, Y.-H., and Chiang, W. 2001. Antagonism of free-radical induced damage of adlay seed and its antiproliferative effect in human histolytic lymphoma U937 monocytic cells. J. Agric. Food Chem. 49:1564-1570.
Kuwada, S.K., Neklason, D.W., and Burt, R.W. 2002. Biology and molecular genetics of colorectal cancer. In Colorectal Cancer: Multimodality Management, L.B. Saltz (Ed), p3-21, Human Press Inc., Totowa, NJ.
Lee, K.-H., Wang, H.-K., Itokawa, H., and Morris-Natschke, S.L. 2000. Current perspectives on Chinese Medicines and dietary supplements in China, Japan and the United States. J. Food Drug Anal. 8:219-228.
Le Leu, R.K. L. Hu, Y., and Young, G.P. 2002. Effects of resistant starch and nonstarch polysaccharides on colonic luminal environment and genotoxin-induced apoptosis in the rat. Carcinogenesis 23:713-719.
Li, B.-S., Chen, X.-H., Ren, W.-L., Lu, H.-Q., Yao, Y.-L., and Yan, H.-F. 1998. Antitumor activity of KangLaiTe injection. Zhongguo Yiyao Gongye Zazhi 29:456-458.
Li, F., Kishida, T., Kobayashi, M. 1999a. Serum iron and ferritin levels in patients with colorectal cancer in relation to the size, site, and disease stage of cancer. J. Gastroenterol. 34:195-199.
Li, H., Schut, H.A.J., Conran, P., Kramer, P.M., Lubet, R.A.,Steele, V.E.,Hawk, E.E., Kelloff, G.J., and Pereira, M.A. 1999b. Prevention by aspirin and its combination with α-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis 20:425-430.
Lin, J.-K. 2000. Mechanisms of cancer chemoprevention by phytochemicals and phytophenols. Food Sci. Agric. Chem. 2:189-201.
Lindblom, A. 2001. Different mechanisms in the tumorigenesis of proximal and distal colon cancer. Curr. Opin. Oncol. 13:63-69.
Lipkin, M. 1995. Strategies for colon cancer prevention. Ann. N.Y. Acad. Sci. 768:170-179.
Liu, T., Mokuolu, A.O., Rao, C.V., Reddy, B.S., and Holt, P.R. 1995. Regional chemoprevention of carcinogen-induced tumors in rat colon. Gastroenterology 109:1167-1172.
Lynch, J.P. and Hoops, T.C. 2002. The genetic pathogenesis of colorectal cancer. Hematol. Oncol. Clin. N. Am. 16:775-810.
Marks, F., Furstenberger, G., and Muller-Decker, K. 1999. Metabolic targets of cancer chemoprevention: Interruption of tumor development by inhibitors of arachidonic acid metabolism. 1999. In Chemoprevention of Cancer: A Clinical Update, H.-J. Seen, A, Costa, and V.C. Jordan (Ed), p.45-67, Spring-Verlag Berlin, Heidelberg, Berlin.
McIntosh, G.H., Royle, P.J., and Pointing, G. 2001. Wheat aleurone increase cecal β-glucuronidase activity and butyrate concentration and reduces colon adenoma burden in azoxymethane-treated rats. J. Nutr. 131:127-131.
Moreau, R.A., Singh, V., and Hicks, K. 2001. Comparison of oil and phytosterol levels in germplasm accessions of corn, teosinte, and job’s tears. J. Agric. Food Chem. 49:3793-3795.
Morse, M.A., Kresty, L.A., and Toburen, A.L.1995. Inhibition of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by dietary benzaldehydes. Cancer Lett. 97:255-261.
Nagai, T., Ishizuka, S., Hara, H., and Aoyama, Y. 2000. Dietary sugar beet fiber prevents the increase in aberrant crypt foci induced by γ-irradiation in the colorectum of rats treated with an immunosuppressant. J. Nutr. 130:1682-1687.
Neil, G.A. and Bruce, W.R. 1988. Experimental approaches to colon cancer prevention in human. Gastroenterol. Clin. North Am. 17:917-930.
Numata, M., Yamamoto, A., Moribayashi, A., and Tamada, H. 1994. Antitumor compounds isolated from the Chinese herbal medicine Coix lachryma-jobi. Planta Med. 60:356-359.
Ohno, Y., Fukuda, K., Takemura, G., Toyota, M., Watanabe, M., Yasuda, N., Xinbin, Q., Maruyama, R., Akao, S., Gotou, K., Fujiwara, T., and Fujiwara, H. 1999. Induction of apoptosis by gallic acid in lung cancer cells. Anti-Cancer Drugs 10:845-851.
Ohtsubo,K.-I., Yanagi, S.O., and Yanase, H. 1985. Properties of a trypsin inhibitor from Job’s tears (Coix lachryma-jobi L.var. ma-yuen Stapf). Agric. Biol. Chem. 49:1985-1991.
Ota, S., Bamba, H., Kato, C., Kawamoto, C., Yoshida, Y., and Fujiwara, K. 2002. Review article: COX-2, prostanoids and colon cancer. Aliment. Pharmacol. Ther. 16:102-106.
Parnaud, G., Tache, S., Peiffer, G., and Corpet, D.E. 1999. Polyethylene-glycol suppresses colon cancer and cause dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats. Cancer Res. 59:5143-5147.
Pereira, M.A., Barnes, L.H., Rassman, V.L., Kelloff, G.V., and Steele, V.E. 1994. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15:1049-1054.
Potter, J.D. 1995. Risk factors for colon neoplasia – Epidemiology and biology. Eur. J. Cancer 31A:1033-1038.
Potter, J.D. 1999. Colorectal cancer: Molecules and populations. J. Natl. Cancer Inst. 91:916-932.
Pozharisski, K.M. 1975. Morphology and morphogenesis of experimental epithelial tumors of the intestine. J. Natl. Cancer Inst. 54:1115-1135.
Prosky, L., Asp, N.G., Schmeizer, T.F., DeVries, J.W., and Furda, I. 1988. Determination of insoluble, soluble, and total dietary fiber in foods and food products: interlaboratory study. J. Assoc. Off. Anal. Chem. 71:1017-1023.
Rao, C.V., Rivenson, A., Katiwala, M., Kelloff, G.J., and Reddy, B.S. 1993. Chemoprevention effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res. 53:2502-2506.
Rao, C.V., Rivenson, A., Simi, B., and Reddy, B.S. 1995. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55:25-266.
Rao, C.V., Wang, C-Q., Simi, B., Rodriguez, J.G., Cooma, I., El-Bayoumy, K., and Reddy, B.S. 2001. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Cancer Res. 61:3647-3652.
Reddy, B.S. 1998. Colon carcinogenesis models for chemoprevention studies. Hemato./Oncol. Clin. North Am. 12:963-973.
Reddy, B.S., Hirose, Y., Cohen, L.A., Simi, B., Cooma, I., and Rao, C.V. 2000a. Preventive potential of wheat bran fracions against experimental colon carcinogenesis: Implications or human colon cancer prevention. Cancer Res. 60:4792-4797
Reddy, B.S., Hirose, Y., Lubet, R., Steele, V., Kelloff, G., Paulson, S., Seibert, K., and Rao, C.V. 2000b. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitors, celecoxib, administered during different stages of carcinogenesis. Cancer Res. 60:293-297.
Reddy, B.S. and Rao.C.V. 2003. Role of synthetic and naturally ccurring cyclooxygenase inhibitors in colon cancer prevention. In COX-2 blockade in Cancer Prevention and Therapy, R.E. Harris (Ed), p71-83, Humana Press Inc., Totowa, NJ.
Reddy, R.S., Rao, C.V., Rivenson, A., and Kelloff, G. 1993. Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res. 53:3493-3498.
Rock, C.L. 1998. Nutritional factors in cancer prevention. Hemato./Oncol. Clin. North Am. 12:975-991.
Roncucci, L. 1992. Early events in human colorectal carcinogenesis aberrant crypts and microadenoma. Ital. Gastroenterol. 24:498-501.
Roy, H.K., Karolski, W.J., and Ratashak, A. 2001. Distal bowel selsctivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone. Int. J. Cancer 92:609-615.
Sakuma, K., Fujimori, T., Hirabayashi, K., and Terano, A. 1999. Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer. J. Gastroenterol. 34:189-194.
Salucci, M., Stivala, L.A., Maiani, G., Bugianesi, R., and Vannini, V. 2002. Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2). Brit. J. Cancer 86:1645-1651.
Shao, J., Sheng, H., Aramandla, R., Pereira, M.A., Lubert, R.A., Hawk, E., Grogan, L., Kirsch, I.R., Washington, M.K., Beauchamp. R.D., and DuBois, R.N. 1999. Coordinate regulation of cyclooxygenase-2 and TGF-β1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis 20:185-191.
Shih, C.-K., Chiang, W., and Kuo, M.-L. 2004. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats. Food Chem. Toxicol. 42:1339-1347.
Singh, J., Hamid, R., and Reddy, B.S. 1997. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res. 57:3465-3470.
Slattery, M.L., Edwards, S., Boucher, K.M., Anderson, K., and Caan, B.J. 1999. Lifestyle and colon cancer: An assessment of factors associated with risk. Am. J. Epidemiol. 150:869-877.
Slemmer, J.R. and Cooper, H.S. 1991. Carcinoma of the colon and rectum. In Pathology of the Colon, Small Intestine, and Anus, H.T. Norris (Ed), p225-262, Churchill Livingstone Inc. New York, NY.
Stinson, S.F. 1990. Spontaneous tumor in fischer rats. In Atlas of Tumor Pathology of the Fischer Rat, S.F. Stinson, H.M. Schuller, and G.K. Reznik (Ed), p1-18, CRC Press, Inc., Boca Raton, Florida.
Swan, D.K. and Ford, B. 1997. Chemoprevention of cancer: Review of the literature. Oncol. Nurs. Forum 24:719-727.
Takahashi, M., Konno, C., and Hikino, H. 1986. Isolation and Hypoglycemic activity of coixans A, B and C, glycans of Coix lachryma-jobi var. ma-yuen seeds. Planta Med. 52:64-65.
Takayama, T., Katsuki, S., Takahashi, Y., Ohi, M., Nojiri, S., Sakamaki, S., Kato, J., Kogawa, K., Miyake, H., and Niitsu, Y. 1998. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N. Engl. J. Med. 339:1277-1284.
Takeshita, M., Ueda, H., Shirabe, K., Higuci, Y., and Yoshida,S. 1997. Lack of promotion of colon carcinogenesis by high oleic safflower oil. Cancer 79: 1487-1493.
Talbot, S.M. and Neugut, A.I. 2002. Epidemiological trends in colorectal cancer. In Colorectal Cancer: Multimodality Management, L.B. Saltz (Ed), p.23-46, Human Press Inc., Totowa, NJ.
Tanaka, T., Makita, H., Kawabata, K., Mori, H., Sumida, T., Tanaka, T., and Ogawa, H. 1997. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis. 18:957-965.
Tanaka, T., Shimizu, M., Kohno, H., Yoshitani, S., Tsukio, Y., Murakami, A., Safitri, R., Takahashi, D., Tamamoto, K., Koshimizu, K., Ohigashi, H., and Mori, H. 2001. Chemoprevention of azoxymethane-induced rats aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. Life Sci. 69:1935-1945.
Tayek, J.A., Istfan, N.W., Jones, C.T., Hamawy, K.J., Bistrian, B.R., and Blackburn, G.L. 1986. Influence of the walker 256 carcinosarcoma on muscle, tumor, and whole-body protein synthesis and growth rate in the cancer-bearing rat. Cancer Res. 46:5649-5654.
Thorup, I., Meyer, O., and Kristianesen, E. 1995. Effect of potato starch, cornstarch and sucrose on aberrant crypt foci in rats exposed to azoxymethane. Anticancer Res. 15:2101-2106.
Tokuda, H., Matsumoto, T., Konoshima, T., Kozuka, M., Nishino, H., and Iwashima, A. 1990. Inhibitory effect on Epstein-Barr virus activation and anti-tumor promoting activities of Coix seed. Planta Med. 56:653-654.
Tsukamoto, T., Kozaki, K., Nishikawa, Y., Yamamoto M., Fukami, H., Inoue, M., Wakabayashi, K., and Tatematsu, M. 1999. Development and distribution of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine. Jpn. J. Cancer Res. 90:720-725.
Uchida, K., Kado, S., Ando, M., Nagata, Y., Takagi, A., and Onoue, M. 2001. A mucinous histochemical study on malignancy of aberrant crypt foci (ACF) in rat colon. J. Vet. Med. Sci. 63:145-149.
Uchida, K., Kado, S., Onoue, M.,and Tohyama, K. 1997. Relationship between the nature of mucus and crypt multiplicity in aberrant crypt foci in the rat colon. Jpn. J. Cancer Res. 88:807-814.
Ukita, T. and Tanimura, A. 1961. Studies on the anti-tumor component in the seeds of Coix Iachryma-jobi L. var. Ma-yuen (Roman) stapf I. Isolation and anti-tumor activity of coixenolide. Chem. Pharm. Bull. 9:43-46.
Wang, H.K., Xia, Y., Yang, Z.Y., Natschke, S.L. Lee K.H. 1998. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. Advances in Experimental Medicine and Biology 439:191-225.
Ward, J.M. 1974. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab. Invest. 30:505-543.
Ward, J.M., Yamamoto, R.S., and Brown, C.A. 1973. Pathology of intestinal neolasms and other lesions in rats exposure to azoxymethane. J. Natl. Cancer Inst. 51:1029-1039.
Wargovich, M.J. 1996. Precancer markers and prediction of tumorigenesis. In Prevention and Early Detection of Colorectal Cancer. G.P. Young, P. Rozen, and B. Levin (Ed), p89-101, W.B. Saunders Company Ltd, London.
Wargovich, M.J., Jimenez, A., Mckee, K., Steele, V.E., Velasco, M., Woods, J., Price, R., Gray, K., and Kelloff, G.J. 2000. Effect of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 21:1149-1155.
Weber, R.V., Stein, D.E., Scholes, J., and Kral, J.G. 2000. Obesity potentiates AOM-induced colon cancer. Dig. Dis. Sci. 45:890-895.
Weihrauch, J. and Gardner, K.A. 1978. Sterol content of foods of plant origin. J. Am. Diet. Assoc. 73:39-47.
Wiese, F.W., Thompson, P.A., Warneke, J., Einspahr, J., Albert, D.S., and Kadlubar, F.F. 2003. Variation in cyclooxygenase expression levels within the colorectum. Mol. Carcinog. 37:25-31.
Williams, C., Shattuck-Brandt, R.L., and DuBois, R.N. 1999a. The role of COX-2 in intestinal cancer. Ann. N. Y. Acad. Sci. 889:72-83.
Williams, C.S., Mann, M., and DuBois R.N. 1999b. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18:7908-7916.
Yamada, H., Yanahira, S., Kiyohara, H., Cyong, J.-C., and Otsuka, T. 1986. Water-soluble glucans from the seed of Coix lachryma-jobi var. ma-yuen. Phytochemistry 25:129-132.
Yamashita, N., Minamoto, T., Onda, M., and Esumi, H. 1994. Increase cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon. Jpn. J. cancer Res. 85:692-698.
Yoshimi, N., Kawabata, K., Hara, A., Matsunaga, K., Yamada, Y., and Mori, H. 1997. Inhibitory effect of NS-398, a selective cycoloxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats. Jpn. J. Cancer Res. 88:1044-1051.
Yoshioka, K., Kataoka, T., Hayashi, T., Hasegawa, M., Ishi, Y., and Hibasami, H. 2000. Induction of apoptosis by gallic acid in human stomach cancer KATO III and colon adenocarcinoma COLO 205 cell lines. Oncology Reports 7:1221-1223.
Zhang, H. and Sun, X.-F. 2002. Overexpression of cyclooxygenase correlates with advanced stages of colorectal cancer. Am. J. Gastroenterol. 97:1037-1041.
Zoran, D.L., Turner, N.D., Taddeo, S.S., Chapkin, R.S., and Lupton, J.R. 1997. Wheat bran diet reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentration. J. Nutr. 127:2217-2225. | zh_TW |